cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.1184/r1/6397013
title: Modeling Productivity in Open Source GitHub Projects: A Dataset and Codebase

description: Contains events associated with 16,337 Python PyPI projects from Github from 2012 through Oct 2017. Scraped from Github (acceptable use per terms of service: https://help.github.com/en/github/site-policy/github-terms-of-service). Also contains analysis of bursts of activity within each project, performed by (1) using a hidden markov model to identify "busy" spans of days, (2) calculating metrics of social and technical dependencies among people and artifacts involved in each burst, and (3) calculating sociotechnical congruence by comparing the social and technical dependency networks.
DOI: 10.6084/m9.figshare.6397010
title: Microbial biofilm inoculants benefit growth and yield of chrysanthemum varieties under protected cultivation through enhanced nutrient availability

description: Protected cultivation of ornamental flowers, as a commercial venture, becomes less profitable with excessive use of fertilizers. The present study examined the influence of microbial biofilm inoculants (<i>Anabaena</i>–<i>Azotobacter, Anabaena</i>–<i>Trichoderma</i> and <i>Trichoderma</i>–<i>Azotobacter</i>) on the availability of soil nutrients and structure of rhizosphere microbial communities in three varieties of chrysanthemum (var. White Star, Thai Chen Queen and Zembla). Varietal-specific responses in growth, enzyme activities, flower yield of plants and availability of soil nutrients were recorded. Dehydrogenase activity was highest in var. White Star treated with the <i>Anabaena</i>–<i>Trichoderma</i> biofilm inoculants. The <i>Anabaena</i>–<i>Azotobacter</i> inoculant enhanced the availability of nitrogen, phosphorus and micronutrients in the soil, besides 40–50% increase in soil organic carbon, as compared to carrier alone or no inoculation. PCR-DGGE profiling of the cyanobacterial communities and qPCR quantification of 16S rRNA abundance of bacteria, archaea and cyanobacteria in the rhizosphere soils, revealed the stronger influences of these inoculants, especially in var. Zembla. Principal Component Analysis (PCA) helped to illustrate that the enhanced microbe-mediated availability of soil macro-and micronutrients, except iron content (Fe), was the most influential factor facilitating improved plant growth and yield parameters. The <i>Anabaena</i>–<i>Azotobacter</i>, and <i>Anabaena–Trichoderma</i> biofilm inoculants, proved superior in all three chrysanthemum varieties.
DOI: 10.6084/m9.figshare.6397010.v1
title: Microbial biofilm inoculants benefit growth and yield of chrysanthemum varieties under protected cultivation through enhanced nutrient availability

description: Protected cultivation of ornamental flowers, as a commercial venture, becomes less profitable with excessive use of fertilizers. The present study examined the influence of microbial biofilm inoculants (<i>Anabaena</i>–<i>Azotobacter, Anabaena</i>–<i>Trichoderma</i> and <i>Trichoderma</i>–<i>Azotobacter</i>) on the availability of soil nutrients and structure of rhizosphere microbial communities in three varieties of chrysanthemum (var. White Star, Thai Chen Queen and Zembla). Varietal-specific responses in growth, enzyme activities, flower yield of plants and availability of soil nutrients were recorded. Dehydrogenase activity was highest in var. White Star treated with the <i>Anabaena</i>–<i>Trichoderma</i> biofilm inoculants. The <i>Anabaena</i>–<i>Azotobacter</i> inoculant enhanced the availability of nitrogen, phosphorus and micronutrients in the soil, besides 40–50% increase in soil organic carbon, as compared to carrier alone or no inoculation. PCR-DGGE profiling of the cyanobacterial communities and qPCR quantification of 16S rRNA abundance of bacteria, archaea and cyanobacteria in the rhizosphere soils, revealed the stronger influences of these inoculants, especially in var. Zembla. Principal Component Analysis (PCA) helped to illustrate that the enhanced microbe-mediated availability of soil macro-and micronutrients, except iron content (Fe), was the most influential factor facilitating improved plant growth and yield parameters. The <i>Anabaena</i>–<i>Azotobacter</i>, and <i>Anabaena–Trichoderma</i> biofilm inoculants, proved superior in all three chrysanthemum varieties.
DOI: 10.6084/m9.figshare.6396992.v2
title: Collaborative task scheduling with new task arrival in cloud manufacturing using improved multi-population biogeography-based optimization

description: This is the experimental data of the manuscript entitled "Collaborative task scheduling with new task arrival in cloud manufacturing using improved multi-population biogeography-based optimization". All data are generated through computer simulation and saved in the file with txt format. The data are consistent with the real-world case. The “illustrative case data.txt” is used in Section 5.2 as illustrative examples corresponding to table 1 and table 2, respectively. Other data are used in Section 5.3 and 5.4.
DOI: 10.6084/m9.figshare.6396992.v1
title: Collaborative task scheduling with new task arrival in cloud manufacturing using improved multi-population biogeography-based optimization

description: This is the experimental data of the manuscript entitled "Collaborative task scheduling with new task arrival in cloud manufacturing using improved multi-population biogeography-based optimization". All data are generated through computer simulation and saved in the file with txt format. The data are consistent with the real-world case. The “illustrative case data.txt” is used in Section 5.2 as illustrative examples corresponding to table 1 and table 2, respectively. Other data are used in Section 5.3 and 5.4.
DOI: 10.6084/m9.figshare.6396923
title: Schizotypy, risk1.sav

description: Dataset for schizotypy and risk-taking behaviour
DOI: 10.6084/m9.figshare.6396923.v1
title: Schizotypy, risk1.sav

description: Dataset for schizotypy and risk-taking behaviour
DOI: 10.6084/m9.figshare.6396833
title: PPI spider of Crohn's disease

description: Protein protein interaction in Crohn's diseases using a bioinformatic approach<br>
DOI: 10.6084/m9.figshare.6396833.v3
title: PPI spider of Crohn's disease

description: Protein protein interaction in Crohn's diseases using a bioinformatic approach<br>
DOI: 10.6084/m9.figshare.12369947.v8
title: Mechanisms of the persistent high primary production during the growing season in the Chukchi Sea

description: This item includes the datasets utilized in the article for submission to Ecosystems.
DOI: 10.6084/m9.figshare.6396416
title: Supplementary Material for: Statin Use during Hospitalization and Short-Term Mortality in Acute Ischaemic Stroke with Chronic Kidney Disease

description: <b><i>Objectives:</i></b> Statin use during hospitalization improves prognosis in patients with ischaemic stroke. However, it remains uncertain whether acute ischaemic stroke patients with chronic kidney disease (CKD) benefit from statin therapy. We investigated the effect of statin use during hospitalization in reducing short-term mortality of patients with ischaemic stroke and CKD. <b><i>Methods:</i></b> Data of first-ever ischaemic stroke patients without a history of pre-stroke statin treatment was derived from the China National Stroke Registry. Patients were stratified according to estimated glomerular filtration rate (eGFR): normal renal function (eGFR ≥90 mL/min/1.73 m<sup>2</sup>), mild CKD (eGFR 60–90 mL/min/1.73 m<sup>2</sup>) and moderate CKD (eGFR &lt; 60 mL/min/1.73 m<sup>2</sup>). Multivariate logistic regression analysis was used to evaluate the association between statin use during hospitalization and all-cause mortality with different renal functions at 3-month follow-up. <b><i>Results:</i></b> Among 5,951 patients included, 2,595 (43.6%) patients were on statin use during hospitalization after stroke (45.7% in patients with normal renal function, 42.0% in patients with mild CKD, and 39.0% in patients with moderate CKD). Compared with the non-statin group, statin use during hospitalization was associated with decreased all-cause mortality in patients with normal renal function (OR 0.65, 95% CI 0.43–0.97, <i>p</i> = 0.04), mild CKD (OR 0.59, 95% CI 0.38–0.91, <i>p</i> = 0.02) and moderate CKD (OR 0.41, 95% CI 0.23–0.75, <i>p</i> = 0.004) at 3-month follow-up. <b><i>Conclusions:</i></b> Statin use during hospitalization was associated with decreased 3-month mortality of ischaemic stroke patients with mild and moderate CKD. However, the conclusion should be confirmed in further studies with larger population, especially with moderate CKD.
DOI: 10.6084/m9.figshare.6396416.v1
title: Supplementary Material for: Statin Use during Hospitalization and Short-Term Mortality in Acute Ischaemic Stroke with Chronic Kidney Disease

description: <b><i>Objectives:</i></b> Statin use during hospitalization improves prognosis in patients with ischaemic stroke. However, it remains uncertain whether acute ischaemic stroke patients with chronic kidney disease (CKD) benefit from statin therapy. We investigated the effect of statin use during hospitalization in reducing short-term mortality of patients with ischaemic stroke and CKD. <b><i>Methods:</i></b> Data of first-ever ischaemic stroke patients without a history of pre-stroke statin treatment was derived from the China National Stroke Registry. Patients were stratified according to estimated glomerular filtration rate (eGFR): normal renal function (eGFR ≥90 mL/min/1.73 m<sup>2</sup>), mild CKD (eGFR 60–90 mL/min/1.73 m<sup>2</sup>) and moderate CKD (eGFR &lt; 60 mL/min/1.73 m<sup>2</sup>). Multivariate logistic regression analysis was used to evaluate the association between statin use during hospitalization and all-cause mortality with different renal functions at 3-month follow-up. <b><i>Results:</i></b> Among 5,951 patients included, 2,595 (43.6%) patients were on statin use during hospitalization after stroke (45.7% in patients with normal renal function, 42.0% in patients with mild CKD, and 39.0% in patients with moderate CKD). Compared with the non-statin group, statin use during hospitalization was associated with decreased all-cause mortality in patients with normal renal function (OR 0.65, 95% CI 0.43–0.97, <i>p</i> = 0.04), mild CKD (OR 0.59, 95% CI 0.38–0.91, <i>p</i> = 0.02) and moderate CKD (OR 0.41, 95% CI 0.23–0.75, <i>p</i> = 0.004) at 3-month follow-up. <b><i>Conclusions:</i></b> Statin use during hospitalization was associated with decreased 3-month mortality of ischaemic stroke patients with mild and moderate CKD. However, the conclusion should be confirmed in further studies with larger population, especially with moderate CKD.
DOI: 10.6084/m9.figshare.6396407
title: Data from Volunteer 3

description: These are the raw data from Volunteer 3 (male, 30), from a project in which the energetic costs of firewood collection were measured.
DOI: 10.6084/m9.figshare.6396407.v1
title: Data from Volunteer 3

description: These are the raw data from Volunteer 3 (male, 30), from a project in which the energetic costs of firewood collection were measured.
DOI: 10.6084/m9.figshare.6396404
title: Data from Volunteer 2

description: These are the raw data from Volunteer 2 (male, 40), from a project in which the energetic costs of firewood collection were measured.
DOI: 10.6084/m9.figshare.6396404.v1
title: Data from Volunteer 2

description: These are the raw data from Volunteer 2 (male, 40), from a project in which the energetic costs of firewood collection were measured.
DOI: 10.6084/m9.figshare.6396389
title: Supplementary Material for: Trajectories of Antidepressant Use before and after the Loss of a Family Member: Evidence from the Finnish Public Sector Study

description: Medicine
DOI: 10.6084/m9.figshare.6396389.v1
title: Supplementary Material for: Trajectories of Antidepressant Use before and after the Loss of a Family Member: Evidence from the Finnish Public Sector Study

description: Medicine
DOI: 10.6084/m9.figshare.6396380
title: Data from Volunteer 1

description: These are the raw data from Volunteer 1 (female, 35), from a project in which the energetic costs of firewood collection were measured. <br>
DOI: 10.6084/m9.figshare.6396380.v1
title: Data from Volunteer 1

description: These are the raw data from Volunteer 1 (female, 35), from a project in which the energetic costs of firewood collection were measured. <br>
DOI: 10.6084/m9.figshare.6396374
title: Database Peripartum Fetal Distress Excel

description: Dataset Peripartum Fetal Distress in Diabetic Women
DOI: 10.6084/m9.figshare.6396296
title: Practical statistical considerations for investigating anti-tumor treatments in mice

description: Anti-tumor treatment outcomes in mouse experiments can be challenging to interpret and communicate accurately. In reporting these experiments, rigorous statistical considerations are commonly absent, although statistical applications have been proposed. We investigated the practicality and utility of different statistical strategies for the analysis of anti-tumor responses in a longitudinal mouse case study. Each analysis that we performed had different endpoints, investigated different questions, and was based on different assumptions. We found rudimentary visual and risk analysis insufficient without additional considerations, and upon further investigation we found improvements in key anti-tumor parameter estimates associated with a drug combination in our case study. We offer practical statistical considerations for investigating anti-cancer treatments in mice, applying a multi-tier statistical approach.
DOI: 10.6084/m9.figshare.6396296.v1
title: Practical statistical considerations for investigating anti-tumor treatments in mice

description: Anti-tumor treatment outcomes in mouse experiments can be challenging to interpret and communicate accurately. In reporting these experiments, rigorous statistical considerations are commonly absent, although statistical applications have been proposed. We investigated the practicality and utility of different statistical strategies for the analysis of anti-tumor responses in a longitudinal mouse case study. Each analysis that we performed had different endpoints, investigated different questions, and was based on different assumptions. We found rudimentary visual and risk analysis insufficient without additional considerations, and upon further investigation we found improvements in key anti-tumor parameter estimates associated with a drug combination in our case study. We offer practical statistical considerations for investigating anti-cancer treatments in mice, applying a multi-tier statistical approach.
DOI: 10.6084/m9.figshare.6396257.v2
title: Figures for the manuscript and supporting information (SI): The Influence of Chemical Change on Protein Dynamics: A Case Study with Pyruvate Formate-Lyase

description: We provide original Scheme 1 (cdx) and Figure 1-8 (png) for the corresponding manuscript together with Figure S1-S25 (png) for SI.
DOI: 10.6084/m9.figshare.6396257
title: Figures for the manuscript and supporting information (SI): The Influence of Chemical Change on Protein Dynamics: A Case Study with Pyruvate Formate-Lyase

description: We provide original Scheme 1 (png) and Figure 1-9 (png) for the corresponding manuscript together with Figure S1-S25 (png) for SI.
DOI: 10.6084/m9.figshare.6396248
title: High rise premise plumbing 2

description: Illumina 16S amplicon sequencing for QIIME
DOI: 10.6084/m9.figshare.6396248.v1
title: High rise premise plumbing 2

description: Illumina 16S amplicon sequencing for QIIME
DOI: 10.5281/zenodo.4007725
title: Storage. Speicherung von Forschungsdaten. SUH.

description: Leitfragen zur Ermittlung des Bedarfs:<br> 1. Wie viel Speicher benötigen Sie im Durchschnitt?<br> 2. Welche Kriterien müsste eine Infrastruktur erfüllen, um Ihren<br> Anforderungen gerecht zu werden? Die Fragen an das Forschungsprojekt beziehen sich auf Ihre<br> Forschungsdaten:<br> ● Welche Datentypen und welche Datenformate fallen in Ihrem Projekt<br> an?<br> ● Bitte schätzen Sie Umfang/Volumen der Forschungsdaten ein<br> (ungefähre Größenordnung, d.h. weniger als 100 GB, 1 TB, 10 TB,<br> 100 TB)?<br> ● Können Sie Aussagen zur Datenqualität machen? (z.B. Text: Wie<br> viele Seiten? PDF, Word? Printqualität, Webqualität u.ä.;<br> Audiointerview: Wieviel Stunden? Stereo, Mono? Ist eine<br> Sendequalität erforderlich?<br> ● Sind die Daten besonders schutzwürdig oder öffentlich (Frage nach<br> der Sensibilität)?<br> ● Wo speichern Sie die Forschungsdaten, die im Rahmen Ihrer<br> Projekte anfallen und zu welchem Zweck sollen die Daten aufbewahrt<br> werden? (mit Angabe der Aufbewahrungsdauer, wenn möglich)<br> ● Werden Sie Ihre Daten lokal oder in einem fachspezifischen,<br> externen Repositorium speichern (mit Begründung, wenn möglich)?<br> ● Mit welchen Metadaten bzw. Metadatenstandards arbeiten Sie im<br> Projekt (sofern dies schon der Fall sein sollte)?<br> Metadaten sind strukturierte Informationen, die die vorliegenden<br> Daten näher beschreiben. Während formatspezifische Metadaten,<br> auch technische Metadaten genannt, Auskunft über Dateityp, -größe<br> und Erstelldatum geben, enthalten deskriptive Metadaten<br> Informationen über den Inhalt der Daten, die die Auffindbarkeit,<br> Nachnutzung und Zitierbarkeit der Daten erleichtern.<br> UNEKE zielte insbesondere in der wisseschaftlichen Begleitstudie auf die Frage, was<br> Forschende abhält bzw. ermutigt zukünftig Daten zu publizeren und zu teilen.
DOI: 10.6084/m9.figshare.6396062.v1
title: Raw data.zip

description: 24,331 papers related to hepatocellular carcinoma research from 2008 to 2017 that were downloaded from Web of Science Core Collection database on March 31, 2018.
DOI: 10.6084/m9.figshare.6396062.v2
title: Raw data for "Trends in hepatocellular carcinoma research from 2008 to 2017: A bibliometric analysis."

description: 24,331 papers related to hepatocellular carcinoma research from 2008 to 2017 that were downloaded from Web of Science Core Collection database on March 31, 2018.
DOI: 10.6084/m9.figshare.6396062.v4
title: Raw data for "Trends in hepatocellular carcinoma research from 2008 to 2017: A bibliometric analysis."

description: The 24,331 papers related to hepatocellular carcinoma research between 2008 to 2017. Data were downloaded from the Web of Science Core Collection database on March 31, 2018.
DOI: 10.6084/m9.figshare.6396062.v6
title: Raw data for "Trends in hepatocellular carcinoma research from 2008 to 2017: A bibliometric analysis."

description: The 24,331 papers related to hepatocellular carcinoma research between 2008 to 2017. Data were downloaded from the Web of Science Core Collection database on March 31, 2018.
DOI: 10.6084/m9.figshare.6396062.v7
title: Raw data for "Trends in hepatocellular carcinoma research from 2008 to 2017: A bibliometric analysis."

description: The 24,331 papers related to hepatocellular carcinoma research between 2008 to 2017. Data were downloaded from the Web of Science Core Collection database on March 31, 2018.
DOI: 10.6084/m9.figshare.6396050
title: MasterChart_May_31_2018.xlsx

description: A randomized control trial to compare efficacy and safety of cyclophosphamide and mycophenolate mofetil among patients with lupus nephritis.
DOI: 10.6084/m9.figshare.6396050.v1
title: MasterChart_May_31_2018.xlsx

description: A randomized control trial to compare efficacy and safety of cyclophosphamide and mycophenolate mofetil among patients with lupus nephritis.
DOI: 10.6084/m9.figshare.6396026
title: High rise premise plumbing 1

description: Illumina 16S amplicon sequencing for QIIME
DOI: 10.6084/m9.figshare.6396026.v2
title: High rise premise plumbing 1

description: Illumina 16S amplicon sequencing for QIIME
DOI: 10.6084/m9.figshare.6396026.v1
title: High rise premise plumbing 1

description: Illumina 16S amplicon sequencing for QIIME
DOI: 10.6084/m9.figshare.6395984
title: Full dataset

description: <b>Background:</b> The World Health Organization recommends isoniazid preventive therapy (IPT) for six months for child contacts without tuberculosis (TB), who are exposed to an adult with active TB. The effectiveness of IPT depends on 80% or greater adherence to medication. In the current study, we assessed IPT adherence and explored barriers to and facilitators of adherence among eligible child contacts in Kigali, Rwanda. <b>Methods</b>: A mixed method study design was used to prospectively assess adherence to IPT among eligible child contacts and its associated factors through a quantitative, observational cohort study, and to explore barriers to and facilitators of adherence to IPT through a descriptive qualitative study. <b>Results</b>: Of the 84 child contacts who started IPT, 74 (88%) had complete adherence and ten (12%) incomplete adherence. There were no factors (individual characteristics of index cases, households and or health facility characteristics) found to be significantly associated with IPT adherence in the bivariate and multivariate analysis. In the qualitative analysis, we identified factors relating to parents/caregivers, disease, household and health-care providers as major themes determining IPT adherence. <b>Conclusion</b>:<b> </b>There was a high rate of IPT completion in this cohort of eligible child contacts living in Kigali. However, structural factors (poverty and relocation) were found to be the main barriers to IPT adherence that could be addressed by health-care providers. <br>
DOI: 10.6084/m9.figshare.6395984.v1
title: S1_Data_quantitative study.xlsx

description: Background: World Health Organisation (WHO) recommends Isoniazid Preventive Therapy (IPT) for six months to child contacts without tuberculosis (TB). Child contacts are defined as children under 15 years old who are exposed to an adult with active TB. The effectiveness of IPT depends on medication adherence of 80% or greater. The current study assessed IPT adherence and explored barriers to adherence ineligible child TB contacts in Rwanda.<br>Methods: A mixed method study design was used to prospectively assess adherence to IPT among eligible child contacts and its associated factors through a quantitative, observational cohort study, and to explore barriers and facilitators of adherence to IPT through a qualitative study.<br>Results: Among the 270 child contacts recruited for the main cross-sectional study, 94 (35%) were under 5 years old and eligible for IPT. Eighty-four (89%) started IPT, but 10 (12%) of them did not complete 6 months of IPT. Only one child contact developed TB after IPT completion. There were no factors found to be significantly associated with IPT adherence in a bivariate and multivariate analysis. The qualitative analysis shows that parents/caregivers, household, diseases, health care providers, child-related factors and access are the major sub-themes determining IPT adherence.<br>Conclusion: This study shows that whereas IPT is well managed in Rwanda, barriers to IPT adherence remain, and strategies are needed to address challenges with IPT adherence as part of the National Tuberculosis Programme.